Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
REPLAY HPE Male is a gender-specific human placenta extract developed by RegenMed, specifically formulated for men's health and anti-aging applications. Derived from male-birth placentas, it is processed as a frozen placental protein concentrate to preserve the bioactivity of its constituent growth factors, peptides, hormones, amino acids, vitamins, and trace elements. The product is designed to provide a complex milieu of bioactive molecules that support rejuvenation, metabolic health, and immune function. It is administered via injection and is marketed as the first placenta-based product to offer formulas tailored to the biological differences between male and female placental tissue, recognizing that placentas from male births contain distinct concentrations of key therapeutic components.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on REPLAY HPE Male.